July 12, 2023
EDUCATIONAL PEARL
Head and Neck Melanoma: Malignant cancer of melanocytes
Presenting Symptoms:
ABCDE
A: Asymmetry
B: Irregular borders
C: Color changes (red, blue, white spots in brown/black patches)
D: Diameter > 6 mm
E: Evolving“Ugly Duckling” sign: Nevus evidently different than other surrounding nevi
Most common head and neck sites: occipital scalp and skin of cheek
Risk factors:
UV-B exposure
Severe sunburns in childhood
Pale skin (blue-green eyes)
Immunosuppression
Familial dysplastic nevus syndrome
Previous melanoma
Histopathology: Melanocyte cells that are neural crest in origin (S-100 positive)
Types of melanomas include:
Superficial spreading: Most common; 70% from preexisting junctional nevi; horizontal phase transitions to vertical phase (ulceration);
Nodular: Most aggressive; may present on non sun-exposed skin; worst prognosis
Lentigo Maligna Melanoma: Arises from lentigo maligna (melanoma in-situ from proliferation of melanocytes in basalis layer) in sun-exposed skin; common in the elderly; common on head and neck; confined to epidermis
Acral Lentiginous: Found on soles of feet or hands, more common in darker skin tones
Mucosal melanoma: Found in mucosa instead of skin; poor prognosis; <10% of head and neck melanomas
Amelanotic: Poor prognosis
Desmoplastic
Depth Classification: Breslow Thickness
Depth of invasion in mm
< 1 mm = thin melanoma
> 1 mm usually requires sentinel lymph node biopsy
Diagnosis: Excisional biopsy with > 2 mm margins (never shave biopsy)
Management:
Prevent excess sun exposure
Excision
<1 mm depth: 1 cm margins
1-2 mm depth: >1 cm margins
> 2 mm depth: 2 cm margins
Face: Resect to level of muscles of expression
Parotid: Resect to masseteric fascia
Scalp: Resect to calvarial periosteum
Auricle: Partial or total auriculectomy
EAC: Possible temporal bone resection
Sentinel Node Biopsy
Replaced elective neck dissection
Neck dissection reserved for positive nodes
Predictive of overall and disease-free survival
Chemo/Immuno/Molecular therapy
Radiation: typically reserved for non-surgical and palliative patients
Image 1
Image 2
Image 1 Reference: Scatena C, Murtas D., Tomei S. Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies. Front Oncology. 2021 May; 11.
Image 2 Reference: Lopes, Joana & Rodrigues, Cecilia & Gaspar, Manuela & Reis, Catarina. (2022). Melanoma Management: From Epidemiology to Treatment and Latest Advances. Cancers. 14. 4652.
Further Reading:
General
Sentinel Node Biopsy
Surgical Management
Surgical Management 2
Chemo/Immuno/Molecular Therapy
Immunotherapy
Written by: Graham Pingree